tiprankstipranks
Advertisement
Advertisement

HK:1541 Stock Latest News

ImmuneOnco Starts Phase II/III Trial of First-in-Class IMM0306 for IgG4-Related Disease
Company AnnouncementsImmuneOnco Starts Phase II/III Trial of First-in-Class IMM0306 for IgG4-Related Disease
12d ago
1541
ImmuneOnco flagged by HKEX over shareholder loan compliance
PremiumCompany Announcements
ImmuneOnco flagged by HKEX over shareholder loan compliance
20d ago
1541
ImmuneOnco Dilutes Stake in Subsidiary via De Minimis Connected Capital Injection
PremiumCompany Announcements
ImmuneOnco Dilutes Stake in Subsidiary via De Minimis Connected Capital Injection
1M ago
1541
ImmuneOnco Deploys HK$87.5 Million Into Vital Ventures Cash Management Funds
PremiumCompany Announcements
ImmuneOnco Deploys HK$87.5 Million Into Vital Ventures Cash Management Funds
1M ago
1541
ImmuneOnco plans on-market H-share buyback to signal confidence and boost value
PremiumCompany Announcements
ImmuneOnco plans on-market H-share buyback to signal confidence and boost value
1M ago
1541
ImmuneOnco Shareholders Approve All AGM Resolutions and Grant New Capital Mandates
PremiumCompany AnnouncementsImmuneOnco Shareholders Approve All AGM Resolutions and Grant New Capital Mandates
2M ago
1541
ImmuneOnco Rotates HK$205m Wealth Product Into Larger HK$212m Placement
Premium
Company Announcements
ImmuneOnco Rotates HK$205m Wealth Product Into Larger HK$212m Placement
2M ago
1541
ImmuneOnco Begins Phase II Trial of First-in-Class CD47/CD20 Bispecific IMM0306 for Lupus
Premium
Company Announcements
ImmuneOnco Begins Phase II Trial of First-in-Class CD47/CD20 Bispecific IMM0306 for Lupus
2M ago
1541
ImmuneOnco Sets 2026 AGM to Approve Results, Profit Plan and Share Issuance Mandate
PremiumCompany Announcements
ImmuneOnco Sets 2026 AGM to Approve Results, Profit Plan and Share Issuance Mandate
3M ago
1541
ImmuneOnco Doses First Patient in Phase III Trial of CD47/CD20 Bispecific for Lymphoma
PremiumCompany Announcements
ImmuneOnco Doses First Patient in Phase III Trial of CD47/CD20 Bispecific for Lymphoma
4M ago
1541
ImmuneOnco Advances Timdarpacept to Phase III After Strong Leukemia Trial Data
PremiumCompany Announcements
ImmuneOnco Advances Timdarpacept to Phase III After Strong Leukemia Trial Data
4M ago
1541
ImmuneOnco Completes Key Patient Enrollment in Phase III Trial of Lead Cancer Drug IMM01
PremiumCompany Announcements
ImmuneOnco Completes Key Patient Enrollment in Phase III Trial of Lead Cancer Drug IMM01
4M ago
1541
ImmuneOnco Sets March 2026 Board Meeting to Approve 2025 Annual Results
PremiumCompany AnnouncementsImmuneOnco Sets March 2026 Board Meeting to Approve 2025 Annual Results
4M ago
1541
ImmuneOnco Wins NMPA IND Nod for New Lupus Candidate Amid Share Price Swings
Premium
Company Announcements
ImmuneOnco Wins NMPA IND Nod for New Lupus Candidate Amid Share Price Swings
5M ago
1541
ImmuneOnco Grants Connected Loan to Chairman for Tax Compliance Needs
Premium
Company Announcements
ImmuneOnco Grants Connected Loan to Chairman for Tax Compliance Needs
5M ago
1541
ImmuneOnco Nears Interim Milestone in Phase III Trial of Lead CD47 Drug IMM01
PremiumCompany Announcements
ImmuneOnco Nears Interim Milestone in Phase III Trial of Lead CD47 Drug IMM01
6M ago
1541
ImmuneOnco Wins NMPA Nod to Test Lead CD47 Drug IMM01 in Atherosclerosis
PremiumCompany Announcements
ImmuneOnco Wins NMPA Nod to Test Lead CD47 Drug IMM01 in Atherosclerosis
6M ago
1541
ImmuneOnco Reclaims Global Rights to Key Immuno-Oncology Assets IMM2510 and IMM27M
PremiumCompany Announcements
ImmuneOnco Reclaims Global Rights to Key Immuno-Oncology Assets IMM2510 and IMM27M
7M ago
1541
ImmuneOnco CEO Increases Stake, Signaling Confidence in Growth
PremiumCompany Announcements
ImmuneOnco CEO Increases Stake, Signaling Confidence in Growth
8M ago
1541
ImmuneOnco’s Phase III Study of Innovative Lymphoma Treatment Approved
PremiumCompany AnnouncementsImmuneOnco’s Phase III Study of Innovative Lymphoma Treatment Approved
8M ago
1541
ImmuneOnco Redeems and Subscribes to Wealth Management Products
Premium
Company Announcements
ImmuneOnco Redeems and Subscribes to Wealth Management Products
8M ago
1541
ImmuneOnco Biopharmaceuticals Updates Articles Following Share Placement
Premium
Company Announcements
ImmuneOnco Biopharmaceuticals Updates Articles Following Share Placement
8M ago
1541

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >